- ホーム
- > 洋書
- > ドイツ書
- > Mathematics, Sciences & Technology
- > Medicine & Pharmacy
- > general medicine, diagnostics, therapy, basics
Full Description
It is amazing that in the first years of the 21st century there are insufficient blood supplies and that some supplies are unsafe in certain areas of the world. Regulations and codes call for continuous improvement in processes and attitudes to assure safety everywhere. To that end nearly 200 transfusionists and their colleagues gathered in Sydney in October 2005 to conduct a marathon symposium on methods and advances made towards achieving universal safety for blood and blood product transfusion. Sponsors of the latest products joined in to support this extraordinary meeting of information and ideas. Advances in transfusion safety were put forward from all areas of the blood transfusion process, including establishment of services, donor selection, infections that may affect donors, safe testing, risk and safety assessment, the roles of government and regulation, the use of blood and its products as well as the need for effective communication. The resulting papers from internationally renowned experts are published in these proceedings.
Contents
Optimal Use as a Route to Blood Safety; Why Do We Believe in Red Cell Transfusion? McClelland, B.; Clinicians as Gatekeepers: What Is the Best Route to Optimal Blood Use? Isbister, J.P.; Emerging Infectious Agents; Parasitic Infections in the Blood Supply: Assessing and Countering the Threat: Wendel, S.; Leiby, D.A.; Reacting to an Emerging Safety Threat: West Nile Virus in North America: Stramer, S.L.; Fitting New Techniques into the Safety Paradigm; Fitting New Technologies into the Safety Paradigm: Use of Microarrays in Transfusion: Fournier-Wirth, C.; Coste, J.; The Utility of Multiplex NAT in Blood Screening: Candotti, D.; Allain, J.-P.; Evolving Approaches to Estimate Risks of Transfusion-Transmitted Viral Infections: Incidence-Window Period Model after Ten Years: Busch, M.P.; Value of HCV Antigen-Antibody Combined HCV Assay in Hepatitis C Diagnosis: Lambert, N.; Characterization of Scrapie-Infected and Normal Hamster Blood as an Experimental Model for TSE-Infected Human Blood: Gregori, L.; Rohwer, R.G.; Regulation as a Driver for Blood Safety; Iron and Blood Donation - An Under-Recognised Safety Issue: Farrugia, A.; The European Blood Directive - Its Role in Blood Safety: Seitz, R.; Supply and Safety through One Agency - The Singapore Experience: Teo, D.; Lim, P.S.; Transfusion and Blood Safety in the Asia-Pacific; The New Japanese Blood Law: Its Impact on Blood Safety and Usage: Tadokoro, K.; Domestic and Imported Products - The Malaysian Experience in Assuring Safe and Sufficient Plasma Products: Ayob, Y.; Blood Safety - A Focus on Plasma Derivatives in Mainland China: Zhu, Y.M.; Advances in Quality Assurance of Laboratory Testing for Transfusion Safety: Dax, E.M.; Walker, S.; Improved Safety of Clinical Blood Transfusion in Four Provinces of China 1997-2005: Whyte, G.; Harmonising Practice and Product - The Role for Blood Safety; Modelling Outcomes of HCV in Recipients of Blood Products: Whyte, G.; Is Haemovigilance Improving Transfusion Practice? - The European Experience: Strengers, P.F.W.; Product Traceability and Lookback: Assuring the Integrity of the Transfusion Process: Flanagan, P.; Emerging Risks and their Communication; Emerging Infections and Global Blood Safety: Dodd, R.Y.; Management of Transfusion Related Risks: Is Risk Communication to Non-Experts at all Possible? Hossenlopp, C.; Blood Safety in the New Millenium - Scientific Purity and Political Reality - Can They be Synthesised for the Public Good? Starr, D.
